NEVIRAPINE- nevirapine tablet 
Cipla Ltd.

----------

MEDICATION GUIDE

Nevirapine Tablets USP, 200mg

(ne-VIR-a-peen)

What is the most important information I should know about nevirapine?

Nevirapine can cause severe liver and skin problems that may lead to death. These problems can happen at any time during treatment, but your risk is higher during the first 18 weeks of treatment.

Nevirapine can cause serious side effects, including:

People who have higher CD4+ cell counts when they begin nevirapine have a higher risk of liver problems, especially:

Stop taking nevirapine and call your doctor right away if you have any of the following symptoms of liver problems with or without a skin rash:

Stop taking nevirapine and call your doctor right away if you get a rash with any of the following symptoms:

          blisters

          muscle or joint aches

          red or inflamed eyes, like "pink eye" (conjunctivitis)

          swelling of your face

          fever

          feel unwell or like you have the flu

          tiredness

See "What are the possible side effects of nevirapine?" for more information about side effects.

What is nevirapine?

Nevirapine is a prescription HIV-1 medicine used with other HIV-1 medicines to treat HIV-1 (Human Immunodeficiency Virus 1) in adults and in children 15 days of age or older. HIV is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).

Do not take nevirapine:

Before taking nevirapine, tell your doctor about all your or your child's medical conditions, including if you or your child:

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Especially tell your doctor if you take St. John's wort.

How should I take nevirapine?

Starting nevirapine tablets:

  1. Your doctor should start you with 1 dose each day to lower your chance of getting a serious rash. It is important that you only take 1 dose of nevirapine each day for the first 14 days.
    • Call your doctor right away if you get a skin rash during the first 14 days of nevirapine treatment.
    • Do not increase your dose to 2 times a day if you have a rash.
    • You should never take your starting dose for longer than 28 days. If after 28 days you are still receiving this starting dose because you have a rash, you and your doctor should talk about prescribing another HIV-1 medicine for you instead of nevirapine.
  2. Day 15, you will take 1 nevirapine tablet 2 times a day.

Switching from nevirapine tablets to nevirapine extended-release tablets:

What are the possible side effects of nevirapine?

Nevirapine may cause serious side effects, including:

See "What is the most important information I should know about nevirapine?"

The most common side effect of nevirapine is rash.

Nevirapine may cause decreased fertility in females. Talk to your doctor if you have concerns about fertility.

These are not all the possible side effects of nevirapine. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store nevirapine tablets?

Keep nevirapine tablets and all medicines out of the reach of children.

General information about the safe and effective use of nevirapine tablets

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not take nevirapine for a condition for which it was not prescribed. Do not give nevirapine tablets to other people, even if they have the same condition you have. It may harm them. You can ask your pharmacist or doctor for information about nevirapine that is written for health professionals.

For more information, go to www.cipla.com or call Cipla Limited at 1-866-604-3268.

What are the ingredients in nevirapine tablets?

Active Ingredient: Nevirapine

Inactive ingredients:

Nevirapine Tablets USP 200 mg: microcrystalline cellulose (Avicel pH 101), corn starch, lactose monohydrate (lactose 200), sodium starch glycolate (primojel) and magnesium stearate.

This Medication Guide has been approved by the U.S. Food and Drug Administration.

CIPLA LTD.

Verna Industrial Estate,

Goa 403722

INDIA

Revised: 10/ 2018

Revised: 11/2018
Cipla Ltd.